OPCML intronic transcript 2 (OPCML-IT2)

OPCML intronic transcript 2 (OPCML-IT2) is a non-coding RNA gene located within the locus of the OPCML (opioid binding protein/cell adhesion molecule-like) gene family. Unlike the canonical OPCML gene, which encodes a glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecule and functional tumor suppressor protein [1][2][8], OPCML-IT2 does not encode a protein and has no known function, disease association, or validated therapeutic relevance described in the literature or major gene/protein databases [3][4][6]. No biological function, disease linkage, or drug interaction is currently established for OPCML-IT2. The designation “intronic transcript” indicates it is an RNA product arising from a non-coding region within the OPCML gene; such transcripts are sometimes detected in transcriptomic analyses but require further study to determine their relevance. This entry is considered problematic for therapeutic or functional target annotation because: - OPCML-IT2 is a transcript (likely a long non-coding RNA or uncharacterized intron-derived RNA), not a protein or functional receptor/enzyme/target. - There is no evidence it acts as a therapeutic target, biomarker, or has any mechanistic or biological function assigned in current scientific resources [3][4][6]. - Its status as a target is likely based on confusion with the canonical OPCML protein, which is well-studied as a tumor suppressor and cell adhesion molecule [1][2][5][8]. Further research or clarification would be needed to extract structured, actionable data for OPCML-IT2, as it is not currently recognized as a druggable or disease-associated target.

Other names

OPCML-IT2OPCML intronic transcript 2 (non-protein coding)